Lifitegrast

FDA Drug Profile — Xiidra, Lifitegrast

Drug Details

Generic Name
Lifitegrast
Brand Names
Xiidra, Lifitegrast
Application Number
NDA208073
Sponsor
ScinoPharm Taiwan Ltd.
NDC Codes
15
Dosage Forms
POWDER, SOLUTION/ DROPS, FOR SOLUTION
Routes
OPHTHALMIC
Active Ingredients
LIFITEGRAST

Indications and Usage

1 INDICATIONS AND USAGE Xiidra ® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Xiidra (lifitegrast ophthalmic solution) 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED). ( 1 )